Lobbying Relationship

Client

Novartis

Pharmaceutical Company More records

Lobbying firm

WINNING STRATEGIES WASHINGTON

More records

  • FY13 Department of Defense Appropriations Orphan drugs and tax issues PDUFA
  • Patient Protection and Innovative Biologic Medicines Act of 2009 Implementation of health care reform Implementation and progress of the deficit reduction committee

Duration: to

General Issues: Budget/Appropriations, Health Issues, Copyright/Patent/Trademark, Agriculture, Consumer Issues/Safety/Protection, Pharmacy

Spending: about $590,000 (But it's complicated. Here's why.)

Agencies lobbied since 2007: House of Representatives, U.S. Senate

Bills mentioned

H.R.142: National Strategic Gasoline Reserve for Purposes of National Security...

Sponsor: Larry Kissell (D-N.C.)

H.R.1548: Right to Rent Act of 2011

Sponsor: Raúl M. Grijalva (D-Ariz.)

H.R.142: Enforce Immigration Law Act of 2009

Sponsor: Elton Gallegly (R-Calif.)

H.R.1548: Pathway for Biosimilars Act

Sponsor: Anna G. Eshoo (D-Calif.)

H.R.3200: America's Affordable Health Choices Act of 2009

Sponsor: John D. Dingell (D-Mich.)

H.R.3326: Department of Defense Appropriations Act, 2010

Sponsor: John P. Murtha (D-Pa.)

H.R.1908: Patent Reform Act of 2007

Sponsor: Howard L. Berman (D-Calif.)

S.1145: Patent Reform Act of 2007

Sponsor: Patrick J. Leahy (D-Vt.)

H.R.1956: Patient Protection and Innovative Biologic Medicines Act of 2007

Sponsor: Jay Inslee (D-Wash.)

S.1505: Affordable Biologics for Consumers Act

Sponsor: Judd Gregg (R-N.H.)

Show All Mentioned Bills

Lobbyists

Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.

Lobbyist Covered positions?
Donna Mullins Ms. n/a
Michael Merola Mr. n/a
Robert Zucker Mr. n/a
Alex DelPizzo Mr. n/a
Donna Mullins n/a
Robert Zucker n/a
Alex DelPizzo n/a
Michael Merola n/a

Disclosures Filed

Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.

Registration
Termination
Amendment
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Registration

Source: Clerk of the U.S. House of Representatives and Secretary of the Senate

Close Comment Creative Commons Donate Email Facebook Mobile Phone Podcast Print Google News logo Google_NewsInitiative_Lockup_FullColor RSS Search Search Twitter WhatsApp Resolving differences Check Building Arrow right Info circle Oops OOPS Pencil File text Bars Search Close Cogs Filter Compare Revolving Door Info card Activity Member menu Globe Document External link Quote News Calendar No Vote
Current site Current page